Table 4 Median values of S100A12 according to clinical characteristics and treatment
| Â | Â | Â | S100A12 | Â |
|---|---|---|---|---|
| Â | Â | N | Median (Interquartile range) | P* |
Activity | Active | 40 | 70.5(42.6-142.2) | 0.546 |
| Â | Inactive | 88 | 64.5(43.1-192.3) | Â |
Extraintestinal manifestations | None | 77 | 63.9(38.6-153.7) | 0.293 |
|  | ≥1 | 51 | 78.5(51.6-156.9) |  |
5-ASA | No | 25 | 61.2(34.3-133.2) | 0.210 |
| Â | Yes | 103 | 74.4(44.2-157) | Â |
Corticosteroids | No | 57 | 63.9(37.3-136.4) | 0.285 |
| Â | Yes | 71 | 74.4(47.6-157) | Â |
Immunosuppressants | No | 93 | 64.5(43.1-142.2) | 0.340 |
| Â | Yes | 35 | 83.5(42.9-282.0) | Â |
Anti-TNF | No | 109 | 69.5(43.6-152.6) | 0.896 |
| Â | Yes | 19 | 70.5(38.6-157.0) | Â |